RPRX N - Royalty Pharma plc - Diagramværktøj

Royalty Pharma plc
MX ˙ BMV ˙ GB00BMVP7Y09
Teknisk Analyse

Tekniske indikatorer er værktøjer, der kan hjælpe handlende med at træffe beslutninger om deres handelsaktiviteter.

Other Listings
DE:RPD 30,12 €
US:RPRX 36,24 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista